As the most and third most common type of CDG, the numbers of patients suffering from PMM2-CDG (~ 1000 cases) and ALG1-CDG (~ 100 cases), respectively, are rapidly increasing worldwide [11–13]. This evidence concerns the gene ALG1 and congenital disorder of glycosylation.